Drug intelligence / Profile preview

CT1194D

Development stage
Phase 1
Lead developer
Chongqing Precision Biotech Co., Ltd
Modality
CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
Administration
Intravenous
01

Overview

CT1194D is an investigational chimeric antigen receptor T-cell (CAR-T) therapy being developed for the treatment of relapsed or refractory B-cell neoplasms, including B-cell non-Hodgkin's lymphoma (B-NHL) and B-cell acute lymphoblastic leukemia (B-ALL). Developed by Chongqing Precision Biotech, CT1194D consists of autologous T-cells genetically modified to express a CAR targeting the B-lymphocyte antigen CD19. The therapy is specifically engineered to optimize cellular metabolic kinetics, a feature intended to improve the metabolic fitness, persistence, and anti-tumor activity of the CAR-T cells within the clinical environment. It is currently being evaluated in early-phase clinical trials to determine its safety, efficacy, and metabolic profile in patients who have failed standard therapies.

Other names
CT1194D CAR-T CellsCT-1194D CAR-T CellsCT 1194D CAR-T Cells

Beyond the preview

Go deeper on CT1194D.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CT1194D.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call